An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line

Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2018, Vol 6, Issue 1

Abstract

The objective of the current experiment was to evaluate the potential of Consciousness Energy Healing-based test items (Vitamin D3 and DMEM) on bone parameters. Both the TI were distributed into two individual parts. One part of each samples was received Consciousness Energy Healing Treatment by Eileen Mary Meagher and those samples were labelled as the Biofield Treated (BT) samples, while the other parts of each samples were denoted as the untreated test items (UT). Cell viability data showed more than 71% viable cells signifies a safe and nontoxic profile of test items on MG-63 cell line. ALP was significantly increased by 132.18% and 126.52% in BT-DMEM+UT-TI and BT-DMEM+BT-TI, respectively at 50 μg/mL; while 139.06% (at 0.1 μg/mL) in UT-DMEM+BT-TI compared to untreated. Collagen was significantly increased by 172.76% at 1 μg/mL in UT-DMEM+BT-TI, while 89.65% in BT-DMEM+UT-TI at 10 μg/mL than untreated. Additionally, collagen was significantly increased by 111.2% in BT-DMEM+UT-TI at 50 μg/mL, while 113.16% in BT-DMEM+BT-TI at 100 μg/mL than untreated. The percent of bone mineralization was significantly increased by 206.21%, 168.74%, and 224.82% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 0.1 μg/mL compared with the untreated. In addition, percent of bone mineralization data showed a significant increased by 190.63%, 181.07%, and 245.41% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 1 μg/mL than untreated. Moreover, at 10 μg/mL it was significantly increased by 129.44%, 111.76%, and 109.81% in UT-DMEM+BT-TI, BT-DMEM+UT-TI, and BT-DMEM+BT-TI, respectively at 10 μg/mL with respect to untreated. Based on the study outcomes it emphasized that Biofield Energy Treatment could regulates the osteoblast function, improves bone mineralization, and calcium absorption in wide range of bone disorders along with wide range of autoimmune diseases.

Authors and Affiliations

Snehasis Jana

Keywords

Related Articles

Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats

Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...

Use of Intravenous Acetaminophen to Reduce Opioid Use in Patients Undergoing Bariatric Surgery at a Community Teaching Hospital

Purpose: The use of intravenous (IV) acetaminophen has been evaluated in several clinical trials and systematic reviews and has been shown to be an effective pain medication that can reduce the need for opioids. Recently...

Mathematical Model of Pharmacokinetic Behavior of Orally Administered Prednisolone in Healthy Volunteers

The objective of the current study was to develop mathematical models that described the pharmacokinetic behavior of prednisolone in healthy subjects after the oral administration of prednisolone. The current study is a...

Instability of Cefpodoxime Proxetil Oral Suspension at Different Temperature Storage Conditions

The advantages of oral dosage form over other dosage forms are responsible for its popularity which includes its ease of administration, patient compliance and stability of the formulation. This study compared the stabil...

Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments

Drugs with low aqueous solubility and permeability possess substantial challenges in designing effective and safe formulations. Synergistic solubility and permeability enhancement in a simple formulation can increase bio...

Download PDF file
  • EP ID EP486676
  • DOI 10.13188/2327-204X.1000023
  • Views 83
  • Downloads 0

How To Cite

Snehasis Jana (2018). An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line. Journal of Pharmaceutics & Pharmacology, 6(1), 1-6. https://europub.co.uk/articles/-A-486676